Browse through a list of organisations that can provide support and information on treatment and therapy options.
This group meets on the 1st and 3rd Friday each month. The group is for anyone affected by stroke and their carers. Speakers and activities are part of the social opportunities available. The club also has a QI Gong session at each meeting. This is a chinese energy exercise which focuses on strengthening your core, breathing and balance.
This leaflet explains how occupational therapy is key to helping your rehabilitation after a stroke.
The Douglas Drive Speech Tharapy Group welcomes membership from people affected by stroke in and around the Stevanage area. The group provides peer and communication support and offers social and recreational activities including games, conversation, outings, talks and presentations by visiting speakers.
Calling all speech and language therapists who see people with progressive aphasia to support new research into speech and language therapy practices for this group.
Thousands of stroke survivors with visual problems could improve their sight from the comfort of their own home using two new web-based therapies.
What maintains stroke survivors’ continued use of self-managed computer therapy for aphasia?
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
People with aphasia are at risk of becoming depressed and isolated. However, due to their language difficulties they are often excluded from stroke research exploring effective interventions. This research will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used with people with aphasia.
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.